Various investigations have demonstrated that neurons lacking Tau are resistant to Aβ-induced neurotoxicity in vitro and that reducing endogenous Tau levels in AD mouse models can mitigate Aβ-induced synaptotoxicity and memory impairments [53, 54]. This evidence concerns the gene MAPT and Alzheimer disease.